Clinical trial

Efficacy of Cilostazol in Prevention of Peripheral Neuropathy

NCT05298696

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2022-03-28

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2022-03-28Date precision: day

Registry last updated2023-03-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Peripheral Neuropathyunresolved

Breast Cancerunresolved

Interventions

CilostazolDRUG · verified · RxNorm: cilostazol

PlaceboDRUG

Sponsors & collaborators

Mansoura Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05298696 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.